MH
Mark Hopman sold $16K of BBNX stock
Mark Hopman, Chief Commercial Officer of Beta Bionics, Inc. (BBNX), sold 821 shares of BBNX stock worth $16K, per an SEC Form 4 filed Oct 28, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 26, 2026, 2 days before it was made public.
BBNX has moved -34.9% since the trade date, from $20.51 to $13.36 (Nov 20, 2026 close).
- Traded
- Oct 26, 2026
- Disclosed
- Oct 28, 2026
- Filing delay
- 2 days
- Price since
- -34.9%
- Role
- Chief Commercial Officer
- Source
- SEC Form 4